BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21450101)

  • 21. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.
    Moon EK; Carpenito C; Sun J; Wang LC; Kapoor V; Predina J; Powell DJ; Riley JL; June CH; Albelda SM
    Clin Cancer Res; 2011 Jul; 17(14):4719-30. PubMed ID: 21610146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.
    Owen JL; Criscitiello MF; Libreros S; Garcia-Areas R; Guthrie K; Torroella-Kouri M; Iragavarapu-Charyulu V
    Cell Immunol; 2011; 270(2):172-82. PubMed ID: 21621198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
    Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
    Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells.
    Xu M; Wang S; Qi Y; Chen L; Frank JA; Yang XH; Zhang Z; Shi X; Luo J
    Mol Carcinog; 2016 May; 55(5):1002-11. PubMed ID: 26014148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
    Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
    PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2.
    Kalderén C; Stadler C; Forsgren M; Kvastad L; Johansson E; Sydow-Bäckman M; Svensson Gelius S
    Int Immunopharmacol; 2014 May; 20(1):66-73. PubMed ID: 24583146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
    Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
    Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cells swarm by homotypic chemokine signalling.
    Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
    Elife; 2020 Oct; 9():. PubMed ID: 33046212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
    Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
    J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes.
    Wang H; Nemoto-Sasaki Y; Kondo T; Akiyama M; Mukaida N
    Int Immunopharmacol; 2003 May; 3(5):627-42. PubMed ID: 12757733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury.
    Xu P; Zhang F; Chang MM; Zhong C; Sun CH; Zhu HR; Yao JC; Li ZZ; Li ST; Zhang WC; Sun GD
    J Neuroinflammation; 2021 Mar; 18(1):64. PubMed ID: 33653377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCL2/CCR2 signaling pathway in glioblastoma multiforme.
    Vakilian A; Khorramdelazad H; Heidari P; Sheikh Rezaei Z; Hassanshahi G
    Neurochem Int; 2017 Feb; 103():1-7. PubMed ID: 28025034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine (C-C Motif) Ligand 2/Chemokine Receptor 2 (CCR2) Axis Blockade to Delay Chondrocyte Hypertrophy as a Therapeutic Strategy for Osteoarthritis.
    Wang Z; Wang B; Zhang J; Wu Z; Yu L; Sun Z
    Med Sci Monit; 2021 Dec; 27():e930053. PubMed ID: 34876548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.
    Ksiazkiewicz M; Gottfried E; Kreutz M; Mack M; Hofstaedter F; Kunz-Schughart LA
    Immunobiology; 2010; 215(9-10):737-47. PubMed ID: 20605053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
    Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
    Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
    Xu M; Wang Y; Xia R; Wei Y; Wei X
    Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
    Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
    FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.